VC Roundup: Flagship’s New Fund Designed To Raise Its Stake In Startups

Newly renamed Flagship Pioneering has raised a $285m venture capital fund to remain invested in portfolio companies as they grow. Also, 12 new and growing biopharma companies raised $657.15m.

trading

Flagship Ventures – now known as Flagship Pioneering – recently changed its name to reflect its focus on life science startups and raised a new $285m fund so that it can boost its ownership stake as companies that the venture capital firm has created evolve.

Cambridge, Massachusetts-based Flagship often does more than just acquire some intellectual property and build a company around it. The VC firm invests in the underlying science, developing the technology in-house before financing the platform that’s built or the therapeutic candidates that are discovered in Flagship’s own labs

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Business

More from Scrip